LV10108A - Sunu proliferacijas inhibitori farmaceitiska kompozicija savienojumu iegusanas metode sunu proliferacijas inhibesanas panemieni - Google Patents

Sunu proliferacijas inhibitori farmaceitiska kompozicija savienojumu iegusanas metode sunu proliferacijas inhibesanas panemieni

Info

Publication number
LV10108A
LV10108A LV920589A LV920589A LV10108A LV 10108 A LV10108 A LV 10108A LV 920589 A LV920589 A LV 920589A LV 920589 A LV920589 A LV 920589A LV 10108 A LV10108 A LV 10108A
Authority
LV
Latvia
Prior art keywords
dog
proliferation
pharmaceutical composition
acquisition methods
composition compound
Prior art date
Application number
LV920589A
Other languages
English (en)
Other versions
LV10108B (en
Inventor
Ole Didrik Laerum
Original Assignee
Hafslund Nycomed Bioreg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hafslund Nycomed Bioreg filed Critical Hafslund Nycomed Bioreg
Publication of LV10108A publication Critical patent/LV10108A/lv
Publication of LV10108B publication Critical patent/LV10108B/lv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4722—G-proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C07K7/067—Hemoregulatory peptides based on sequence Glp-Glu-Asp-Cys-Lys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
LVP-92-589A 1988-09-16 1992-12-30 Inhibitors of cells proliferation, pharmaceutical composition, process of producing of compounds, methods of inhibition of cellular proliferation LV10108B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888821785A GB8821785D0 (en) 1988-09-16 1988-09-16 Peptide compounds
PCT/EP1989/001071 WO1990002753A1 (en) 1988-09-16 1989-09-13 Peptide compounds

Publications (2)

Publication Number Publication Date
LV10108A true LV10108A (lv) 1994-05-10
LV10108B LV10108B (en) 1994-10-20

Family

ID=10643722

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-92-589A LV10108B (en) 1988-09-16 1992-12-30 Inhibitors of cells proliferation, pharmaceutical composition, process of producing of compounds, methods of inhibition of cellular proliferation

Country Status (22)

Country Link
US (1) US5484770A (lv)
EP (2) EP0359338B1 (lv)
JP (1) JPH04500666A (lv)
KR (1) KR900701828A (lv)
CN (1) CN1041159A (lv)
AT (1) ATE110742T1 (lv)
AU (1) AU641366B2 (lv)
CA (1) CA1339947C (lv)
DE (1) DE68917837T2 (lv)
DK (1) DK39591A (lv)
ES (1) ES2058479T3 (lv)
GB (1) GB8821785D0 (lv)
GE (1) GEP19971041B (lv)
HU (2) HU208027B (lv)
IE (1) IE64181B1 (lv)
LT (1) LT3714B (lv)
LV (1) LV10108B (lv)
MY (1) MY104909A (lv)
NZ (1) NZ230654A (lv)
RU (1) RU2079509C1 (lv)
WO (1) WO1990002753A1 (lv)
ZA (1) ZA896980B (lv)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5620957A (en) * 1989-07-14 1997-04-15 Smithkline Beecham Corporation Hemoregulatory peptides
HU206372B (en) * 1990-09-03 1992-10-28 Richter Gedeon Vegyeszet Process for producing new oligopeptides which selectively inhibit proliferation of haemopoietic cells and pharmaceutical compositions comprising same
HU206374B (en) * 1990-09-03 1992-10-28 Richter Gedeon Vegyeszet Process for producing pentapeptide and its salts specifically inhibiting proliferation of epidermic cells, as well as pharmaceutical compositions comprising same as active ingredient
TW222280B (lv) * 1991-11-26 1994-04-11 Smithkline Beecham Corp
IL104323A0 (en) * 1992-01-10 1993-05-13 Smithkline Beecham Corp Hemoregulatory peptides
GB9211668D0 (en) 1992-06-02 1992-07-15 Nycomed Bioreg As Peptide compounds
GB9211674D0 (en) 1992-06-02 1992-07-15 Nycomed Bioreg As Peptide compounds
GB9211677D0 (en) 1992-06-02 1992-07-15 Nycomed Bioreg As Peptide compounds
GR1001502B (el) * 1992-11-26 1994-02-28 Smithkline Beecham Corp Αιμορυ?μιστικά πεπτίδια.
CN1034735C (zh) * 1993-01-02 1997-04-30 史密丝克莱恩比彻姆公司 血调节肽
US5521284A (en) * 1994-08-01 1996-05-28 Arizona Board Of Regents Acting On Behalf Of Arizona State University Human cancer inhibitory pentapeptide amides and esters
US5504191A (en) * 1994-08-01 1996-04-02 Arizona Board Of Regents Acting On Behalf Of Arizona State University Human cancer inhibitory pentapeptide methyl esters
EP1070727A1 (en) * 1999-03-01 2001-01-24 Aventis Pharma Deutschland GmbH Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction
CN1403474A (zh) * 2001-09-05 2003-03-19 中国人民解放军军事医学科学院生物工程研究所 一种短肽及以其为活性成份的药物
EP1578778B1 (en) * 2002-07-23 2011-01-26 Ipsen Pharma Ghrelin analogs

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA838780B (en) * 1982-11-26 1985-01-30 Nyegaard & Co As Peptide compounds
NO860752L (no) * 1985-06-26 1986-12-29 Bio Tech As Pentapeptider med cellevekstregulerende virkning og fremgangsmaate for fremstilling derav.
US4748154A (en) * 1985-12-24 1988-05-31 Takeda Chemical Industries, Ltd. Peptide derivatives, their production and use
GB8626539D0 (en) * 1986-11-06 1986-12-10 Nycomed As Peptide compounds

Also Published As

Publication number Publication date
HUT58765A (en) 1992-03-30
NZ230654A (en) 1991-10-25
DE68917837T2 (de) 1994-12-22
ZA896980B (en) 1990-06-27
EP0434718A1 (en) 1991-07-03
KR900701828A (ko) 1990-12-04
ATE110742T1 (de) 1994-09-15
DK39591D0 (da) 1991-03-06
CA1339947C (en) 1998-07-07
AU4218389A (en) 1990-04-02
GB8821785D0 (en) 1988-10-19
CN1041159A (zh) 1990-04-11
LT3714B (en) 1996-02-26
IE64181B1 (en) 1995-07-12
US5484770A (en) 1996-01-16
WO1990002753A1 (en) 1990-03-22
LTIP610A (en) 1994-12-27
EP0359338B1 (en) 1994-08-31
LV10108B (en) 1994-10-20
RU2079509C1 (ru) 1997-05-20
HU895788D0 (en) 1991-08-28
MY104909A (en) 1994-06-30
IE892954L (en) 1990-03-16
HU208027B (en) 1993-07-28
JPH04500666A (ja) 1992-02-06
DE68917837D1 (de) 1994-10-06
AU641366B2 (en) 1993-09-23
EP0359338A1 (en) 1990-03-21
ES2058479T3 (es) 1994-11-01
DK39591A (da) 1991-03-06
GEP19971041B (en) 1997-11-26

Similar Documents

Publication Publication Date Title
CA2270289A1 (en) Proteins with enhanced levels of essential amino acids
PT883687E (pt) Receptores de quimiocinas c-c, ckr-5, cc, os seus derivados e as suas utilizacoes
FI921036A7 (fi) TGF-B-proteiinikoostumuksia solun lisäkasvun inhiboimiseksi
LTIP610A (en) Inhibitors of cells proliferation, pharmaceutical composition and method for preparation of compounds
DK0601154T3 (da) BPC-peptider, deres fremstilling og anvendelse
MY106202A (en) Saccharin derivatives useful as proteolytic enzyme inhibitors and preparation thereof.
ATE50693T1 (de) Peptidverbindungen.
NZ224706A (en) Amino acid 1,2-diketo derivatives as renin inhibitors
FI925947A7 (fi) Uusia heterosyklisiä 2-sakkarinyylimetyylikarboksylaatteja, jotka ovatkäyttökelpoisia proteolyyttisten entsyymien inhibiittoreina, niitä sisältäviä koostumuksia ja niiden käyttö
ES2081817T3 (es) Polipeptido con secuencias principales repetidas que se fijan en la celula.
HUP9900506A2 (hu) Protrombinszármazékok
BG97123A (bg) Производни на човешка, стимулирана от жлъчните соли, липаза и фармацевтични състави на тяхна основа
BG88028A (bg) Амиди на циклометилен-1,2-дикарбоксилни киселини с терапевтична активност,методи за получаването им и фармацевтични състави, които ги съдържат
ATE60788T1 (de) Derivat von p-aminophenol mit mucrosekretolytischer fluessiger und antipyretischer wirksamkeit, dessen verfahren zur herstellung und dessen pharmazeutische zusammensetzungen.
IT1216104B (it) Peptidi ad attivita' farmaceutica.
DK0842193T3 (da) Somatostatin-analoge cykliske peptider med hæmmende aktivitet på væksthormon
DE68908958D1 (de) Peptide.
KR900700598A (ko) 프로우로키나제의 저분자량 유도체 및 이를 함유하는 약제학적 조성물
ATE293163T1 (de) Cyclin e spezifische konstrukte und komplexe
FR2654430B1 (fr) Nouveaux derives de peptides, utilisables comme inhibiteurs des collagenases bacteriennes.
CO4900031A1 (es) Nuevas n-cianoiminas triciclicas utiles como inhibidores de transferasa de proteina farnesilo
EP0332999A3 (en) Peptides with inhibitory activity of enzymatic systems, process for their preparation and pharmaceutical compositions containing them
FI893211A7 (fi) Antihypertensiivisiä, N-terminaalisia eetteriaminodioliaminohappojohdannaisia
HUP9601528A2 (hu) Véralvadásgátló hatású peptidszármazékok és a vegyületeket tartalmazó gyógyszerkészítmények
NO910981L (no) Peptidforbindelser.